We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.65%
AUM
$65.6B
AUM Growth
+$9.58B
Cap. Flow
+$6.37B
Cap. Flow %
9.71%
Top 10 Hldgs %
7.83%
Holding
4,198
New
794
Increased
1,441
Reduced
1,175
Closed
737

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$208M
2
CXO
CONCHO RESOURCES INC.
CXO
+$177M
3
CCI icon
Crown Castle
CCI
+$168M
4
WMT icon
Walmart Inc
WMT
+$167M
5
ETR icon
Entergy
ETR
+$157M

Sector Composition

Rank Sector Weight
1 Financials 13.27%
2 Technology 12.59%
3 Healthcare 10.49%
4 Industrials 10.32%
5 Consumer Discretionary 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
3026
DELISTED
Global Blood Therapeutics, Inc.
GBT
$326K ﹤0.01%
10,515
-45,092
-81% -$1.27M
NVLN
3027
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$326K ﹤0.01%
46,307
-151,212
-77% -$1.21M
CRIS icon
3028
Curis
CRIS
$8.03M
$325K ﹤0.01%
+109
New +$403K
SIEN
3029
DELISTED
Sientra, Inc.
SIEN
$325K ﹤0.01%
2,108
-4,695
-69% -$551K
CAF
3030
Morgan Stanley China A Share Fund
CAF
$328M
$324K ﹤0.01%
13,600
-109
-0.8% -$2.45K
BXMX
3031
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$322K ﹤0.01%
23,035
+4,547
+25% +$63K
IYE icon
3032
iShares US Energy ETF
IYE
$1.71B
$322K ﹤0.01%
8,612
+2,618
+44% +$93.1K
SCHR
3033
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$322K ﹤0.01%
+11,930
New +$323K
SCHV
3034
Schwab US Large-Cap Value ETF
SCHV
$16B
$322K ﹤0.01%
18,660
+6,069
+48% +$103K
MTRN icon
3035
Materion
MTRN
$6.13B
$319K ﹤0.01%
+7,389
New +$283K
UBP
3036
DELISTED
Urstadt Biddle Properties Inc.
UBP
$319K ﹤0.01%
17,996
-3,009
-14% -$52.5K
JPC icon
3037
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$317K ﹤0.01%
30,013
+19,145
+176% +$201K
VGM icon
3038
Invesco Trust Investment Grade Municipals
VGM
$565M
$316K ﹤0.01%
+23,562
New +$320K
SFUN
3039
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$316K ﹤0.01%
1,562
-52
-3% -$9.2K
ATRS
3040
DELISTED
Antares Pharma, Inc.
ATRS
$315K ﹤0.01%
97,372
-296,879
-75% -$916K
CLAR icon
3041
Clarus
CLAR
$148M
$314K ﹤0.01%
42,063
-122,598
-74% -$842K
NXDT
3042
NexPoint Diversified Real Estate Trust
NXDT
$236M
$314K ﹤0.01%
+13,609
New +$303K
PFN
3043
PIMCO Income Strategy Fund II
PFN
$703M
$313K ﹤0.01%
+29,296
New +$310K
GDV icon
3044
Gabelli Dividend & Income Trust
GDV
$2.65B
$312K ﹤0.01%
13,952
-18,094
-56% -$397K
BLW icon
3045
BlackRock Limited Duration Income Trust
BLW
$492M
$311K ﹤0.01%
+19,281
New +$307K
ISD
3046
PGIM High Yield Bond Fund
ISD
$417M
$311K ﹤0.01%
20,385
-50,819
-71% -$774K
RT
3047
DELISTED
Ruby Tuesday Georgia
RT
$311K ﹤0.01%
145,134
-49,298
-25% -$102K
CVNA icon
3048
Carvana
CVNA
$80B
$310K ﹤0.01%
+105,690
New +$385K
RLH
3049
DELISTED
Red Lions Hotel Corporation
RLH
$309K ﹤0.01%
35,666
+25,495
+251% +$186K
OLBK
3050
DELISTED
Old Line Bancshares, Inc.
OLBK
$309K ﹤0.01%
11,023
-4,173
-27% -$115K

Similar funds

Millennium Management's Q3 2017 Portfolio in Review

As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.

  • Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
  • Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
  • Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
  • Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
  • Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
  • Millennium Management opened 794 new positions and closed 737 in Q3 2017.
  • Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.

Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.